B

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

Vice President Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeNo salary listedRemote

About the Job

Requirements

  • A Ph.D. in Biostatistics or a related field, with at least 18 years of pharmaceutical industry experience and 10 or more years of experience in the design, analysis, and interpretation of clinical trials, or an equivalent combination of education and experience.
  • At least 5 years in a people management and leadership role.
  • Knowledge and expertise in modern adaptive clinical trial designs, multiplicity testing methods, real-world evidence, and quantitative decision-making.
  • Experience contributing to multiple successful product approvals through NDA/BLA filings.
  • Proven expertise in the disciplines, practices, and procedures pertaining to biostatistics, including development and accountability for relevant quality management systems.
  • Experience with Data Monitoring Committees and/or study steering committees.
  • A hands-on approach, including performing analyses when necessary.
  • Experience with global regulatory agencies.
  • Formal expertise and experience in Bayesian and frequentist statistics.

Responsibilities

  • Ensure the relevance, adequacy, and accuracy of state-of-the-art statistical methods used in company-sponsored clinical development activities and selected nonclinical studies.
  • Oversee statistical activities for regulatory submissions, including NDA/BLA submissions.
  • Ensure clinical data processing conforms to relevant regulatory guidelines and Good Clinical Practice.
  • Contribute to clinical development strategies regarding optimal development programs and study design.
  • Lead and manage junior biostatistics staff.
  • Select, direct, and supervise or manage CRO and contract staff performing outsourced operational activities.
  • Use statistical software, including SAS, EAST, and R, for internal ad hoc data analysis and sample size requests.
  • Participate in clinical development and product management teams in support of organizational objectives.
  • Participate in FDA and other regulatory agency meetings as the company spokesperson for biostatistical topics.
  • Participate in organization-wide process definition, creation, and implementation, with a focus on efficiency and productivity enhancement.
  • Define, monitor, and evaluate relevant performance metrics.
  • Author or review critical product-development documents, including clinical study protocols, statistical analysis plans, data management plans, regulatory briefing documents, regulatory dossiers such as NDAs and MAAs, responses to regulatory questions, scientific abstracts, and manuscripts.
  • Ensure the accuracy of data in public company communications of clinical trial results, including press releases, slide presentations, SEC filings, scientific meeting abstracts, and published manuscripts, and monitor the quality audit process for those communications.
  • Communicate technical concepts to technical and regulatory audiences, and explain them to broader audiences in nontechnical terms without loss of rigor.

Desired Qualifications

  • A small-company attitude that embraces change in a high-risk environment.

About the Company

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

BioCryst Pharmaceuticals develops oral small-molecule drugs aimed at treating rare diseases, with a focus on hereditary angioedema (HAE). The company uses traditional cell biology and medicinal chemistry to design synthetic compounds that target specific protein pathways involved in disease. Its products work as oral therapies that modulate disease-related proteins to reduce symptoms and improve daily functioning, progressing from discovery through clinical trials toward commercialization. BioCryst differentiates itself by concentrating on rare diseases and pursuing oral, non-biologic treatments, leveraging a combined science approach and a patient-focused strategy to bring therapies to market. Its goal is to deliver meaningful, clinically validated treatments that enable patients to engage more fully in everyday activities and improve their quality of life, supported by its drug pipeline and potential licensing opportunities.

Company size
501-1,000
Company stage
IPO
Headquarters
Durham, NC
Founded
1986

Recently Posted Jobs

Explore more opportunities at BioCryst Pharmaceuticals

See more jobs